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Abstract
The stress hormone cortisol is responsible for aspects of metabolism and visceral fat formation that are
hypothesized to be linked to obesity. Cortisol directly and indirectly influences metabolism by stimulating lipolysis as
well as gluconeogenesis, the breakdown of fat and creation of glucose respectively. By interacting with abdominal
organs such as the liver and pancreas, cortisol also increases metabolism through downstream hormones, such as
glucagon and epinephrine. Cortisol intersects a variety of pathways that influence the breakdown of sugar, making it
an important target for metabolic studies.
This study investigates the correlation of mutations in proteins responsible for cortisol action in target tissues,
individually and collectively, to clinical measurements of patients with obesity who are seeking or have already
sought out bariatric surgery. DNA samples and clinical information were collected from patients of the Ellis Hospital
Bariatric Care who were recruited for the study under the supervision of the Ellis Hospital Institutional Review
Board. Genotyping of patient samples was done by performing allele specific-polymerase chain reactions
(AS_PCR) which were then analyzed through agarose gel electrophoresis to look for single nucleotide
polymorphisms (SNPs).
It was found that the mutations throughout the glucocorticoid pathway are present at comparable rates in both
the bariatric population and general population except for three SNPs, BclI, Tthiii, and N363. Therefore, it can be
concluded that there is an increase of mutations in the study population compared to the values for the general
public found in literature for increased sensitivity to cortisol.
There are strong correlations between a mutation in the glucocorticoid receptor (GR) and excess body weight.
This mutation causes conversion of an aspartic acid to a serine (N363S) in the protein sequence which has
previously been shown to cause increased sensitivity to cortisol. As more SNPs are analyzed in combination with
each other, more conclusions may be drawn between SNPs and physiological parameters of the patients. High
correlations may provide evidence that select bariatric surgeries may be more effective in patients with specific
genotypes. If this is the case, bariatric surgery can adopt precision medicine that caters treatment to the patient.

Introduction
● Cortisol, a glucocorticoid
hormone, is the primary steroid
involved in response to stress
● In its cellular pathway, cortisol
binds to the glucocorticoid
receptor (GR), which in turn,
activates a signaling cascade
that results in modification of
gene transcription
● High cortisol sensitivity →
metabolic syndrome, similar
symptoms as Cushing's
disease
○ Obesity (higher BMI)
○ Depression
● Mutant genotypes in these
target SNPs result in high
cortisol sensitivity through the
GR, MR, or HSD, and
consequently, metabolic
syndrome

Glucocorticoids: Cortisol and Cortisone →
workhorses of human stress response
High Cortisol

Low Cortisol

Cortisol, Stress and Depression
Hypothalamic Pituitary Adrenal Axis
• Hypocortisolemia
• Metabolic syndrome
• Addisons’ Disease

Results

Hypothesis

• Hypercortisolemia
• Major Depressive Disorder
• PTSD

P= 0.032

P<0.001

A population of bariatric patients does not have the same allelic frequency
of the specified polymorphisms as that of the general population. If there are
significant differences in allelic frequency in the bariatric population, there
will be a correlation between the single nucleotide polymorphisms and
characteristics of obesity along with the efficacy of distinct bariatric
treatments.

Not Significant

P= 0.004
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Table 1: SNPs associated with the GR
gene and other cortisol-related genes
investigated in this study
Gene

SNPs

Glucocorticoid
Receptor

rs41423247 (BCLI) Hypersensitivity

Mineralocorticoid
Receptor

Gel
Electrophoresis

11 betaHydroxysteroid dehydrogenase,
Type I

Phenotype

rs56149945
(N363)

Hypersensitivity

rs10052957
(TthIII)

Resistant

rs2070951
(RS207)

Hypersensitivity

rs846910 (RS84)

Resistant

rs846910 (RS120)

Hypersensitivity

rs5522 (RS55)

Resistant

Figure 1. Overview of Procedure.

Results
WT

WT

WT

WT

WT MU WT MU WT MU

Hetero

Future Directions

WT MU WT MU WT MU

N363

TthIIIi

0.494
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These values demonstrate the lack of statistical significance of the SNPs studied to BMI.
T-tests were performed between the average BMI of each genotype.
Pooled t-test, mutant has higher excess body weight for N363.

●
●
●
●
●
●

Greater number of samples to determine further statistical significance
Analyze previous samples’ current phenotypic status with more recent data
Find new SNPs within the cortisol pathway to study
Expand SNPs beyond just cortisol pathway
Role of sex in phenotype and genotype
Acquire lipid profile, blood sugar, and blood pressure
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Table 1. P-values of BMI association with SNPs in Bcl1, N363, and TthIIIi.
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Figure 2. Tthiii PCR 02/19/2021 (left) 04/12/2021 (right). Agarose gel electrophoresis. 1KB
ladder. The above bands determine the genotype of the designated samples. Samples with
bands at wild type and mutant marks are heterozygous. The samples with bands only in wild
type or mutant lanes are the respective genotypes.

Bcl1

** = statistically significant at 99% confidence level
* = statistically significant at 95% confidence level

● N363 has statistical significance to excess body weight
○ People with the N363 mutation have higher weights before bariatric surgery
● Bcll, N363, and TthIIIi are different in the bariatric population in comparison to
the general population
○ There is increased sensitivity to cortisol in people with obesity
○ There are genotypic correlations to the bariatric phenotype

Data Analysis
and
Calculations

Genotype
Identification

Figure 2. Allelic Frequency of Single Nucleotide Polymorphisms of Bariatric Sample Population Compared to
General Population values from literature. This graph displays the accepted allelic frequency from literature to
the collected samples through a chi square goodness of fit test, the statistical significance of the allelic frequencies
in the bariatric population was determined. At a p<0.05 significance level, Bcl1, TthIIIi and N363 are significantly
different than the general population.
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